Published in Basic Res Cardiol on June 27, 1986
The inhibition of rabbit skeletal muscle contraction by hydrogen ions and phosphate. J Physiol (1988) 3.17
Force-velocity relations and myosin heavy chain isoform compositions of skinned fibres from rat skeletal muscle. J Physiol (1991) 2.25
Calcium regulation of tension redevelopment kinetics with 2-deoxy-ATP or low [ATP] in rabbit skeletal muscle. Biophys J (1998) 1.76
Orthologous myosin isoforms and scaling of shortening velocity with body size in mouse, rat, rabbit and human muscles. J Physiol (2003) 1.60
Unloaded shortening of skinned muscle fibers from rabbit activated with and without Ca2+. Biophys J (1994) 1.31
Shortening velocity and power output of skinned muscle fibers from mammals having a 25,000-fold range of body mass. J Gen Physiol (1991) 1.27
Mechanics of glycerinated muscle fibers using nonnucleoside triphosphate substrates. Biophys J (1991) 1.08
Force-velocity and power-load curves in rat skinned cardiac myocytes. J Physiol (1998) 1.05
Ca2+ dependence of loaded shortening in rat skinned cardiac myocytes and skeletal muscle fibres. J Physiol (2000) 0.99
Mechanical characterization of skeletal muscle myofibrils. Biophys J (1996) 0.97
Systems biology of skeletal muscle: fiber type as an organizing principle. Wiley Interdiscip Rev Syst Biol Med (2012) 0.88
Thin filament activation and unloaded shortening velocity of rabbit skinned muscle fibres. J Physiol (2003) 0.88
Mechanical properties of respiratory muscles. Compr Physiol (2013) 0.84
When fibres go slack and cross bridges are free to run: a brilliant method to study kinetic properties of acto-myosin interaction. J Physiol (2007) 0.81
Familial hypertrophic cardiomyopathy: functional variance among individual cardiomyocytes as a trigger of FHC-phenotype development. Front Physiol (2014) 0.76
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med (1998) 6.17
Evidence for cross-bridge attachment in relaxed muscle at low ionic strength. Proc Natl Acad Sci U S A (1982) 5.38
Rate of force generation in muscle: correlation with actomyosin ATPase activity in solution. Proc Natl Acad Sci U S A (1986) 4.13
Technique for stabilizing the striation pattern in maximally calcium-activated skinned rabbit psoas fibers. Biophys J (1983) 3.33
X-ray diffraction evidence for cross-bridge formation in relaxed muscle fibers at various ionic strengths. Biophys J (1984) 2.73
Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation. J Thromb Haemost (2005) 2.46
Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis. N Engl J Med (1996) 2.38
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost (2013) 2.24
Comparison of dosage schedules of rt-PA in the treatment of proximal deep vein thrombosis. J Lab Clin Med (1992) 2.22
Did Jesus Christ die of pulmonary embolism? J Thromb Haemost (2005) 2.04
The cross-bridge cycle in muscle. Mechanical, biochemical, and structural studies on single skinned rabbit psoas fibers to characterize cross-bridge kinetics in muscle for correlation with the actomyosin-ATPase in solution. Basic Res Cardiol (1986) 1.92
Stiffness of skinned rabbit psoas fibers in MgATP and MgPPi solution. Biophys J (1986) 1.91
Structures of actomyosin crossbridges in relaxed and rigor muscle fibers. Biophys J (1989) 1.91
Cross-bridge attachment in relaxed muscle. Adv Exp Med Biol (1984) 1.89
Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. J Thromb Haemost (2008) 1.81
Single-molecule tracking of myosins with genetically engineered amplifier domains. Nat Struct Biol (2001) 1.58
Equatorial x-ray diffraction from single skinned rabbit psoas fibers at various degrees of activation. Changes in intensities and lattice spacing. Biophys J (1985) 1.54
Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells. Cell (1997) 1.47
Heparanase neutralizes the anticoagulation properties of heparin and low-molecular-weight heparin. J Thromb Haemost (2006) 1.44
Successful use of recombinant activated factor VII (Novoseven) in controlling severe intra-abdominal bleeding after liver needle biopsy. Thromb Haemost (2002) 1.40
Thrombocytopenia associated with low-molecular-weight heparin. Lancet (1991) 1.39
Mechanical and structural approaches to correlation of cross-bridge action in muscle with actomyosin ATPase in solution. Annu Rev Physiol (1987) 1.39
Diagnosis of femoropopliteal venous thrombosis with MR imaging: a comparison of four MR pulse sequences. AJR Am J Roentgenol (1990) 1.39
Interferon-alpha-2b with VMCP for induction in multiple myeloma: the Israel Myeloma Cooperative Group experience. Isr J Med Sci (1995) 1.38
Treatment of male infertility: the ICSI revolution is secure. N Z Med J (1996) 1.38
Ca2+-sensitive cross-bridge dissociation in the presence of magnesium pyrophosphate in skinned rabbit psoas fibers. Biophys J (1986) 1.36
Cardiac valvular vegetations in cancer patients: a prospective echocardiographic study of 200 patients. Am J Med (1997) 1.32
Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia. Blood Coagul Fibrinolysis (2001) 1.31
Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost (1999) 1.31
Cardiomyopathy mutations reveal variable region of myosin converter as major element of cross-bridge compliance. Biophys J (2009) 1.28
Effect of Ca2+ on weak cross-bridge interaction with actin in the presence of adenosine 5'-[gamma-thio]triphosphate). Proc Natl Acad Sci U S A (1992) 1.27
Calcium activation and maximum unloaded shortening velocity. Investigation on glycerinated skeletal and heart muscle preparations. Basic Res Cardiol (1980) 1.26
International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost (2013) 1.21
Heparanase induces tissue factor expression in vascular endothelial and cancer cells. J Thromb Haemost (2006) 1.21
Increased risk of cancer in patients with Gaucher disease. Cancer (1993) 1.20
Psychological distress among male patients and male spouses: what do oncologists need to know? Ann Oncol (2009) 1.19
The recruitment of research participants: a review. Soc Work Health Care (1993) 1.17
Equilibration and exchange of fluorescently labeled molecules in skinned skeletal muscle fibers visualized by confocal microscopy. Biophys J (1995) 1.16
Retinal arterial occlusion in a child with factor V Leiden and thermolabile methylene tetrahydrofolate reductase mutations. Am J Ophthalmol (1997) 1.13
Incidence, prognostic significance and therapeutic modalities of central nervous system involvement in multiple myeloma. Acta Haematol (1982) 1.10
On the regeneration of the actin-myosin power stroke in contracting muscle. Proc Natl Acad Sci U S A (1993) 1.06
Reluctance of paramedics and emergency medical technicians to perform mouth-to-mouth resuscitation. J Emerg Med (1997) 1.05
Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemost (1999) 1.05
Force enhancement without changes in cross-bridge turnover kinetics: the effect of EMD 57033. Biophys J (1997) 1.03
Special topic: molecular mechanism of muscle contraction. General introduction. Annu Rev Physiol (1987) 1.03
Fas-induced programmed cell death is mediated by a Ras-regulated O2- synthesis. Immunology (1996) 1.03
X-ray diffraction studies of cross-bridges weakly bound to actin in relaxed skinned fibers of rabbit psoas muscle. Biophys J (1997) 1.02
State-dependent radial elasticity of attached cross-bridges in single skinned fibres of rabbit psoas muscle. J Physiol (1993) 1.01
Echocardiography in nonbacterial thrombotic endocarditis: from autopsy to clinical entity. J Am Soc Echocardiogr (2000) 1.00
Use of tranexamic acid mouthwash to prevent postoperative bleeding in oral surgery patients on oral anticoagulant medication. Quintessence Int (1997) 0.99
Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective study on 207 patients. Int J Radiat Oncol Biol Phys (1999) 0.99
Silent pulmonary embolism in patients with proximal deep vein thrombosis in the lower limbs. J Thromb Haemost (2012) 0.98
Familial thrombophilia--the scientific rationale for thrombophylaxis in recurrent pregnancy loss? Hum Reprod (1997) 0.98
The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer (1997) 0.96
Cardiac involvement in patients with myeloproliferative disorders. Am J Med (1992) 0.96
Sarcomeric domain organization within single skinned rabbit psoas fibers and its effects on laser light diffraction patterns. Biophys J (1985) 0.96
Cross-bridge attachment during high-speed active shortening of skinned fibers of the rabbit psoas muscle: implications for cross-bridge action during maximum velocity of filament sliding. Biophys J (2000) 0.96
Expression and characterization of the naturally occurring mutation L394R in human gamma-glutamyl carboxylase. J Biol Chem (2000) 0.95
High-resolution equatorial x-ray diffraction from single skinned rabbit psoas fibers. Biophys J (1986) 0.95
Fas-induced apoptosis is mediated by activation of a Ras and Rac protein-regulated signaling pathway. J Biol Chem (1996) 0.94
[An indirect proof of stretch-induced Ca++ release from the sarcoplasmic reticulum in glycerinated skeletal and heart muscle preparations (author's transl)]. Basic Res Cardiol (1979) 0.94
The effect of thin filament activation on the attachment of weak binding cross-bridges: A two-dimensional x-ray diffraction study on single muscle fibers. Biophys J (1999) 0.93
Microparticles bearing tissue factor and tissue factor pathway inhibitor in gestational vascular complications. J Thromb Haemost (2009) 0.93
A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood (1997) 0.93
A single-fiber in vitro motility assay. In vitro sliding velocity of F-actin vs. unloaded shortening velocity in skinned muscle fibers. J Muscle Res Cell Motil (1999) 0.92
Dental surgery in patients with severe factor XI deficiency without plasma replacement. Blood Coagul Fibrinolysis (1992) 0.92
Placement of hemodialysis catheters through dilated external jugular and collateral veins in patients with internal jugular vein occlusions. AJR Am J Roentgenol (2000) 0.92
Renal extramedullary hematopoiesis simulating hypernephroma. Eur Urol (1991) 0.91
Involvement of weak binding crossbridges in force production in muscle. J Muscle Res Cell Motil (1991) 0.91
Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism. Am J Med (2001) 0.90
Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss. Am J Reprod Immunol (2000) 0.90
Relationship between birthweight and blood pressure in childhood. Am J Kidney Dis (1999) 0.89
A new detection system for extremely small vertically mounted cantilevers. Nanotechnology (2008) 0.89
HIV drug resistance and implications for the introduction of antiretroviral therapy in resource-poor countries. Drug Resist Updat (2001) 0.89
Inaccuracy of "personal best" peak expiratory flow rate reported by inner-city patients with acute asthma. J Asthma (2001) 0.89
Theoretical kinetic studies of models for binding myosin subfragment-1 to regulated actin: Hill model versus Geeves model. Biophys J (2001) 0.89
State-dependent radial elasticity of attached cross-bridges in single skinned fibres of rabbit psoas muscle. J Physiol (1993) 0.89
Venous thromboembolism during pregnancy, postpartum or during contraceptive use. Thromb Haemost (2009) 0.88
Angiosarcoma of the colon developing in a capsule of a foreign body. Report of a case with associated hemorrhagic diathesis. Am J Clin Pathol (1992) 0.88
Activation of the Ras signaling pathway by the CD40 receptor. J Immunol (1996) 0.88
Alcoholism and fatal accidents. Q J Stud Alcohol (1967) 0.88
Expression of the apoptosis-related oncogenes bcl-2, bax, and p53 in Merkel cell carcinoma: can they predict treatment response and clinical outcome? Hum Pathol (1999) 0.88
Topical Biafine and Lipiderm for the prevention of radiation dermatitis: a randomized prospective trial. Oncol Rep (2001) 0.87
Natural porcine surfactant (Curosurf) down-regulates mRNA of tumor necrosis factor-alpha (TNF-alpha) and TNF-alpha type II receptor in lipopolysaccharide-stimulated monocytes. Pediatr Res (1998) 0.87
Classic Kaposi sarcoma: experience at Rabin Medical Center in Israel. Am J Clin Oncol (1998) 0.87
Multiple myeloma with pericardial involvement and cardiac tamponade: a report of three patients. Leuk Lymphoma (1996) 0.87
Colorectal cancer in young patients in Israel: a distinct clinicopathological entity? World J Surg (2010) 0.86
Diminution of inducible lymphokine-activated killer cell activity in individuals with AIDS-related disorders. AIDS (1990) 0.86
Circumcision in hemophilia: the use of fibrin glue for local hemostasis. J Urol (1992) 0.86
Multiple retinal arteriolar occlusions associated with coexisting primary antiphospholipid syndrome and factor V Leiden mutation. Am J Ophthalmol (2000) 0.86
A force transducer for measuring mechanical properties of single cardiac myocytes. Am J Physiol (1999) 0.86
Pancoast's syndrome in multiple myeloma. Acta Haematol (1984) 0.86
Magnetic resonance imaging of blood and clots in vitro. Invest Radiol (1990) 0.86
Lower limb ischaemia in primary antiphospholipid syndrome. Eur J Vasc Surg (1993) 0.85
The association between parental perception of neighborhood safety and asthma diagnosis in ethnic minority urban children. J Urban Health (2012) 0.84
Reactivity patterns of antiphospholipid antibodies and endothelial cells: effect of antiendothelial antibodies on cell migration. J Lab Clin Med (1998) 0.84